PCA 4230

Known as: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, ethyl 2-(3-oxo-1,2-benzisothiazol-2(3H)-yl)ethyl ester, S,S-dioxide, PCA-4230 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2001
012319922001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
1. Tight control of cellular growth is essential to ensure normal tissue patterning and prevent pathological responses. Excessive… (More)
Is this relevant?
1997
1997
1. In the present study we examined the effects of PCA-4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… (More)
Is this relevant?
1997
1997
1 In the present study we examined the e€ects of PCA-4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
1997
1997
The effect of PCA-4230, a new dihydropyridine derivative with a potent antithrombotic activity, on cyclic nucleotide… (More)
Is this relevant?
1994
1994
We have studied the effects of PCA-4230, a new dihydropyridine derivative with antithrombotic activity, on the secretion of dense… (More)
Is this relevant?
1993
1993
The photostability and phototoxic potential of two new 4-alkyl-1,4-dihydropyridines (PCA-4230 and PCA-4248) were investigated… (More)
Is this relevant?
1993
1993
In the present study we described the effects of a new 1,4-dihydropyridine derivative with antithrombotic activity on… (More)
Is this relevant?
1992
1992
The effects of a new antithrombotic compound, PCA-4230, versus ticlopidine were investigated using an experimental thrombosis and… (More)
Is this relevant?